Loading...

Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma

Gliomas appear to be highly immunosuppressive tumors, with a strong myeloid component. This includes MDSCs, which are a heterogeneous, immature myeloid cell population expressing myeloid markers Siglec-3 (CD33) and CD11b and lacking markers of mature myeloid cells including MHC II. Siglec-3 is a mem...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Immunol Immunother
Main Authors: Santegoets, Kim C. M., Gielen, Paul R., Büll, Christian, Schulte, Barbara M., Kers-Rebel, Esther D., Küsters, Benno, Bossman, Sandra A. J. F. H., ter Laan, Mark, Wesseling, Pieter, Adema, Gosse J.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6529385/
https://ncbi.nlm.nih.gov/pubmed/30953118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02332-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!